Aakash Desai, MD

GI-IBD & Assoc. Program Director @AHNGastro || Assistant Prof. of Medicine @DrexelMedicine || Alumni @MayoClinicFLGIH @metrohealthCLE @cwrusom

[Aakash Desai, MD @akMD03]

Check out our narrative review on GLP-1RA use in IBD in @AGA_GHAdvances
Existing data is exciting but not without limitations. Promising RCTs underway.
Appreciate the opportunity and mentorship from @FarrayeIBD

@hanyhabib97 @LinaWahbeh00 @AHNGastro

https://t.co/8nBzJTmynN

[Aakash Desai, MD @akMD03]

Our 📄 on recent trends in advanced therapy utilization for IBD in the US published in @JCC_IBD
@GKochharMD #siddharthsinghmd

https://t.co/cCN8XYwTfA

[Himsikhar Khataniar @Himsikhar1]

☀️ Idea → 🎬 ACG2024 → 📝publication!

What links EoE and IBD?

❓Do IBD patients carry a higher risk of developing EoE?
❓Risk modifiers?
❓Natural history when EoE+IBD vs EoE-only?

@akMD03 @GKochharMD @FarrayeIBD @JHashashMD

🔗 https://t.co/VXEN8OsaBV

[Aakash Desai, MD @akMD03]

GLP-1RA use and clinical outcomes in IBD: Systematic Review and Meta Analysis published in @JCC_IBD. Great collaboration with international colleagues.

https://t.co/gP2WnFr9tz

[AHN Gastroenterology, Hepatology and Nutrition @AHNGastro]

🚀Dive into the future of IBD care at the 7th Annual AHN IBD Summit happening Saturday, October 4, 2025! 🚀
Explore innovations in endoscopic management, updates on biosimilars, & IBD in pregnancy. Register now at https://t.co/gFrkcmKQ1J! #IBDsummit #AHN #gastroenterology

[Indian Journal of Gastroenterology @IJG_Journal]

Efficacy of tirzepatide for weight loss and it’s comparative effectiveness to weight loss surgery in inflammatory bowel disease

@FarrayeIBD @GKochharMD #GITwitter #IBD

https://t.co/kYatP6BU2O

[Aakash Desai, MD @akMD03]

@GKochharMD Thank you! 🙏🏼

[Aakash Desai, MD @akMD03]

Welcome to our new 1st year fellows! Excited to be a part of your fellowship journey. Looking forward to working with all our fellows this year!

[AHN Gastroenterology, Hepatology and Nutrition @AHNGastro]

Gut feeling says these 1st year GI fellows are going to be AMAZING! 🎉 Big welcome to Dr. Jacubowsky, Dr. Gries, Dr. Cohen & Dr. Amin! Plus, HUGE congrats to @AkashGadaniMD, our new Program Director, & @akMD03, our new Associate Program Director! #GIFellows #GI #AHNToday

[Aakash Desai, MD @akMD03]

@Himsikhar1 Congratulations Himsikhar! Onwards and upwards

[Aakash Desai, MD @akMD03]

@phillyIBDdoc @IBDJournals @CrohnsColitisFn @GKochharMD @FarrayeIBD @JHashashMD @MRegueiroMD Thanks @phillyIBDdoc !

[Aakash Desai, MD @akMD03]

We are honored to receive this award from @IBDJournals and @CrohnsColitisFn! Incredibly fortunate to have @GKochharMD as a mentor. Thank you to all the co-authors for their support and expertise @FarrayeIBD @JHashashMD @MRegueiroMD

[Aakash Desai, MD @akMD03]

@NabeehaMohyudd1 Thank you @NabeehaMohyudd1 !

[Aakash Desai, MD @akMD03]

@jalpa_devi Thank you @jalpa_devi !

[Aakash Desai, MD @akMD03]

@SaadJavedMD @GKochharMD Thanks @SaadJavedMD !

[Aakash Desai, MD @akMD03]

Great collaboration between @MilestoneIBD alumni @phillyIBDdoc
Thank you to @APandT for publishing our work! @GKochharMD @FarrayeIBD @Himsikhar1 @AHNGastro

[roypounder.apt @APandT]

Patients with obesity and ulcerative colitis are at an increased risk of composite outcome of steroid use, change in advanced therapy and colectomy.
Read the paper by Desai et al at https://t.co/U1KOYNOS7i
#obesity #ulcerativecolitis #IBD #GItwitter

[Priya Sehgal MD MS MPH @phillyIBDdoc]

Excited to share: Obesity assoc w worse outcomes in UC @APandT

@akMD03 @JamesLewisGIEpi @PennIBDDoc @GKochharMD @FarrayeIBD

✔️UC pts w/ BMI > 30 had inc risk of steroid use, change in therapy, and colectomy

✔️Seen in pts on vedo, UST, anti-TNF & JAKi

https://t.co/X6DYvRZoYe